Match tier Confirmed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Michael O′Connor

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Post Doctoral Researcher

Also affiliated: Supélec (2009); Roche (Switzerland) (2013); Cincinnati Children's Hospital Medical Center (1996–2022); Merck & Co., Inc., Rahway, NJ, USA (United States) (2013); Biogen (United States) (2013); Pennsylvania State University (2007); University of Debrecen (1999); California Department of Food and Agriculture (1991); Center for Drug Evaluation and Research (2013); University of Massachusetts Lowell (2022); University College London Hospitals NHS Foundation Trust (2025); University of Wisconsin–Madison (1994); Royal College of Surgeons in Ireland (2022–2024); University of Liverpool (2007–2022); University of Applied Sciences and Arts of Southern Switzerland (2009); University of Auckland (2022); University of Illinois Urbana-Champaign (1977); Indiana University – Purdue University Fort Wayne (1990); Merck KGaA, Darmstadt (Germany) (2013); Illinois College (1979); Eli Lilly (United States) (2013); Sigma-Tau (Switzerland) (1991); Pfizer (United States) (2013); University of Aberdeen (2022–2025); University of Washington (2013); Trinity College (2025); Trinity College Dublin (2025); Savannah River National Laboratory (1992); Marine Conservation Institute (2007); Cork University Hospital (2010); Department of Health and Aged Care (2003); University of Bristol (2020); California University of Pennsylvania (2007); University of Chicago (2024); AgResearch (1991); Bristol-Myers Squibb (United States) (2013); Chris O’Brien Lifehouse (2022); Shandong University of Political Science and Law (2009); GlaxoSmithKline (United States) (2013–2018); BD Biosciences (United States) (2013); Department of Animal Health (2017); St. Finbarr's Hospital (2010); Mary Kay (United States) (2020); Applied Spectra (United States) (1991); Conservation Science Partners (2007); Absorption Systems (United States) (2013); Sanofi (Germany) (2013); AstraZeneca (Sweden) (2013); Millennium Engineering and Integration (United States) (2013); Solvo Biotechnology (Hungary) (2013); Eisai (United States) (2013); National University of Equatorial Guinea (2015–2016); Optivia Biotechnology (United States) (2013); Kingston Health Sciences Centre (2019); Micropharma (Canada) (2025); Boehringer Ingelheim (United States) (2013); University College London (2025); University of Baltimore (2007); University of Cincinnati (2004–2018); Martin Luther University Halle-Wittenberg (1997); Drexel University (1992–2024); University of Pennsylvania (2007); University of California, Davis (1991); Newcastle University (2018); Grand Valley State University (2007); University of Cincinnati Medical Center (2009–2018); Philadelphia University (2007)

Postdoc Researcher

43 h-index 173 pubs 8,657 cited

Upstream record may be merged OpenAlex, the source of these figures, lists 68 institutions in 14 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.

  • Animals
  • Male
  • Mice
  • Humans
  • NF-kappa B
  • Sepsis
  • Rats
  • Signal Transduction
  • Temperature
  • Mice, Knockout
  • Phylogeny
  • AMP-Activated Protein Kinases
  • Enzyme Activation
  • Poly(ADP-ribose) Polymerases
  • Tumor Necrosis Factor-alpha

Biography and Research Information

OverviewAI-generated summary

Michael O′Connor's research focuses on understanding biological systems through a variety of approaches, as evidenced by his diverse publications. He has investigated endosymbiont dynamics in pea aphids, examining how seasonal selection and temperature influence these relationships. His work also extends to mammalian models, with studies on the effects of sepsis on endothelial injury and glycocalyx shedding in mice, and the amelioration of these effects using synthetic compounds.

Further contributing to his broad research interests, O′Connor has explored avian metabolic rate allometries, code development for biosynthetic pathways in Diptera, and life history measurements in Daphnia. He has also examined hematological and biochemical parameters in giant pandas. O′Connor's scholarly contributions are reflected in his h-index of 43 and over 8,500 citations across 173 publications, designating him as a highly cited researcher. He collaborates with researchers at the University of Arkansas at Fayetteville, including Taylor Ping, Adam M. Siepielski, Wade A. Boys, and Tara L. Lanzer.

Metrics

  • h-index: 43
  • Publications: 173
  • Citations: 8,657

Selected Publications

  • The reshaping of trade-offs under climate warming (2026)
    Trends in Ecology & Evolution 1 citation DOI OpenAlex
  • Cheating death: selection on digestive physiology overcomes expected growth costs of antipredator defences (2025)
    Journal of Evolutionary Biology DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

4 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics